Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;12(8):1112-8.
doi: 10.1093/europace/euq116. Epub 2010 May 7.

Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial

Sana M Al-Khatib  1 , Gail Hafley, Kerry L Lee, Alfred E Buxton
Affiliations

Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial

Sana M Al-Khatib et al. Europace. 2010 Aug.

Abstract

Aims: We sought to assess the relation between time from myocardial infarction (MI) to enrolment and patient outcomes and to examine the association between these outcomes and implantable cardioverter defibrillator (ICD) therapy.

Methods and results: We analysed the Multicenter UnSustained Tachycardia Trial database (n = 1650). In examining all endpoints, Cox proportional hazards models were used to adjust for potential confounders. There was no significant association between time from MI to enrolment and any of the outcomes (P > 0.1). Inducibility by an electrophysiology study (EPS) was associated with a higher risk of arrhythmic death or cardiac arrest [adjusted hazard ratio (HR) 2.51; 95% confidence interval (CI) 1.64-3.84] and all-cause death (adjusted HR 1.45; 95% CI 1.04-2.03) only in patients who had an MI <or=6 months prior to enrolment. ICD therapy was associated with improved survival in patients who had an MI <or=6 months (adjusted HR 0.35; 95% CI 0.17-0.74) and >6 months before enrolment (adjusted HR 0.34; 95% CI 0.21-0.54).

Conclusion: The risk of arrhythmic death or cardiac arrest and all-cause death did not vary as a function of time from the most recent MI to enrolment. Inducibility by an EPS was associated with worse outcomes only in patients with an MI <or=6 months prior to enrolment. Although ICD therapy was associated with improved survival regardless of the time from MI to enrolment, this finding needs to be verified by a randomized clinical trial.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of time from myocardial infarction to enrolment (≤1 month, >1 month to ≤6 months, >6 months to ≤36 months, >36 months).
Figure 2
Figure 2
Inducibility by an electrophysiology study by time from myocardial infarction to enrolment (≤1 month, >1 month to ≤6 months, >6 months to ≤36 months, >36 months).
Figure 3
Figure 3
(A) Unadjusted arrhythmic death or cardiac arrest by time from myocardial infarction to enrolment. (B) Unadjusted all-cause death by time from myocardial infarction to enrolment. This analysis only included patients who did not receive an implantable cardioverter defibrillator within 90 days after enrolment and were discharged following the index hospitalization on no antiarrhythmic medications.
Figure 4
Figure 4
Unadjusted arrhythmic death or cardiac arrest by time from myocardial infarction to enrolment and inducibility by an electrophysiology study. This analysis only included patients who did not receive an implantable cardioverter defibrillator within 90 days after enrolment and were discharged following the index hospitalization on no antiarrhythmic medications.
See this image and copyright information in PMC

Comment in

References

    1. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Mäkikallio TH, Juhani Airaksinen KE, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2003;42:652–8. doi:10.1016/S0735-1097(03)00783-6. - DOI - PubMed
    1. Solomon S, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581–8. doi:10.1056/NEJMoa043938. - DOI - PubMed
    1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med. 1996;335:1933–40. doi:10.1056/NEJM199612263352601. - DOI - PubMed
    1. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–90. doi:10.1056/NEJM199912163412503. - DOI - PubMed
    1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83. doi:10.1056/NEJMoa013474. - DOI - PubMed

Publication types

MeSH terms